NEW YORK--Manhattan Scientifics Inc. (OTCBB: MHTX) will file its Form 10K with the SEC this week, within the permitted 15 day extension period allowed by the SEC.
The company reports several key current items of interest to its 8,500 shareholders. Among the main points are:
CEO Manny Tsoupanarias stated, "Manhattan Scientifics has had a very successful and active year. Our metals business is running well and on-plan. Manhattan Scientific's Metallicum unit is our core business and its Fortune 1000 industrial partner is providing funding sufficient to cover our entire overhead and cost of all operations, presently and into the foreseeable future.
Manhattan Scientifics, Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.